0B68 Barsevick, Andrea - Thomas Jefferson University - Thomas Jefferson University

Andrea Barsevick, PhD

Contact Dr. Barsevick

834 Chestnut Street
The Franklin Building, Suite 314
Philadelphia, PA 19107

(215) 503-4623
(215) 503-9506 fax

Most Recent Peer-reviewed Publications

  1. Subgroups of Cancer Patients With Unique Pain and Fatigue Experiences During Chemotherapy
  2. Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update
  3. Comparison of groups with different patterns of symptom cluster intensity across the Breast Cancer Treatment Trajectory
  4. Recommendations for high-priority research on cancer-related fatigue in children and adults
  5. The personal patient profile-prostate decision support for men with localized prostate cancer: A multi-center randomized trial
  6. Preparing individuals to communicate genetic test results to their relatives: Report of a randomized control trial
  7. Predictors of depression in breast cancer patients treated with radiation: Role of prior chemotherapy and nuclear factor kappa B
  8. Cancer-related fatigue and its impact on functioning
  9. Cancer symptom cluster research: New perspectives and tools
  10. Common biological pathways underlying the psychoneurological symptom cluster in cancer patients
  11. Clinical subgroups of a psychoneurologic symptom cluster in women receiving treatment for breast cancer: A secondary analysis
  12. Patients' experiences with cancer-related fatigue: A review and Synthesis of qualitative research
  13. Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes
  14. I'm so tired: Biological and genetic mechanisms of cancer-related fatigue
  15. Studying cancer-related fatigue: Report of the NCCN scientific research committee
  16. Confirmatory factor analysis of brief pain inventory (BPI) functional interference clusters in patients with bone metastases
  17. Efficacy of an intervention for fatigue and sleep disturbance during cancer chemotherapy
  18. Cancer-related fatigue
  19. Sleep quality after initial chemotherapy for breast cancer
  20. ASCPRO Recommendations for the Assessment of Fatigue as an Outcome in Clinical Trials